Stockreport

Guardant nabs approval for Guardant360 companion diagnostic for Braftovi [Seeking Alpha]

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF which patients could benefit from Pfizer's ( PFE ) Braftovi ( encorafenib) as a colorectal cancer treatment. The test is used w ith patients with BRAF V600E-mutant met [Read more]